PT1157992E - Derivados de di-hidro-2,3-benzodiazepina - Google Patents

Derivados de di-hidro-2,3-benzodiazepina

Info

Publication number
PT1157992E
PT1157992E PT01114686T PT01114686T PT1157992E PT 1157992 E PT1157992 E PT 1157992E PT 01114686 T PT01114686 T PT 01114686T PT 01114686 T PT01114686 T PT 01114686T PT 1157992 E PT1157992 E PT 1157992E
Authority
PT
Portugal
Prior art keywords
phenyl
alkyl
dihydro
benzodiazepine derivatives
amino
Prior art date
Application number
PT01114686T
Other languages
English (en)
Portuguese (pt)
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Nancy Kay Harn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1157992E publication Critical patent/PT1157992E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
PT01114686T 1994-08-31 1995-08-30 Derivados de di-hidro-2,3-benzodiazepina PT1157992E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US41302995A 1995-03-28 1995-03-28

Publications (1)

Publication Number Publication Date
PT1157992E true PT1157992E (pt) 2005-10-31

Family

ID=26970798

Family Applications (2)

Application Number Title Priority Date Filing Date
PT01114686T PT1157992E (pt) 1994-08-31 1995-08-30 Derivados de di-hidro-2,3-benzodiazepina
PT95930998T PT771198E (pt) 1994-08-31 1995-08-30 Derivados de di-hidro-2,3-benzodiazepina

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT95930998T PT771198E (pt) 1994-08-31 1995-08-30 Derivados de di-hidro-2,3-benzodiazepina

Country Status (13)

Country Link
US (1) US5795886A (zh)
EP (3) EP0771198B1 (zh)
JP (1) JP4131987B2 (zh)
AT (2) ATE212994T1 (zh)
CA (1) CA2198751C (zh)
DE (2) DE69525342T2 (zh)
DK (2) DK0771198T3 (zh)
ES (2) ES2170804T3 (zh)
FI (1) FI113049B (zh)
HK (1) HK1013794A1 (zh)
NZ (1) NZ292417A (zh)
PT (2) PT1157992E (zh)
WO (1) WO1996006606A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA972746B (en) * 1996-04-04 1998-10-09 Egyt Gyogyszervegyeszeti Gyar Novel 2,3-benzodiazepine derivatives
HUP9701325A1 (hu) * 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
HU9803014D0 (en) * 1998-12-23 1999-02-01 Egyt Gyogyszervegyeszeti Gyar Novel phtalazine derivatives, process for their production and pharmaceutical compositions containing the same
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
TW200902024A (en) * 2007-04-02 2009-01-16 Teva Pharma Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
FI970833A0 (fi) 1997-02-27
HK1013794A1 (en) 1999-09-10
NZ292417A (en) 1998-09-24
EP1157992A1 (en) 2001-11-28
DE69525342D1 (de) 2002-03-21
CA2198751C (en) 2006-07-11
DE69534407D1 (de) 2005-09-29
EP0771198B1 (en) 2002-02-06
EP1157992B1 (en) 2005-08-24
JP4131987B2 (ja) 2008-08-13
PT771198E (pt) 2002-06-28
FI970833A (fi) 1997-02-27
ES2170804T3 (es) 2002-08-16
DK0771198T3 (da) 2002-04-22
DE69534407T2 (de) 2006-03-16
JPH10505066A (ja) 1998-05-19
DK1157992T3 (da) 2005-10-24
ATE212994T1 (de) 2002-02-15
WO1996006606A1 (en) 1996-03-07
EP0771198A4 (zh) 1997-05-28
EP1593683A2 (en) 2005-11-09
DE69525342T2 (de) 2002-11-07
EP1593683A3 (en) 2006-10-25
AU689639B2 (en) 1998-04-02
EP0771198A1 (en) 1997-05-07
ES2244524T3 (es) 2005-12-16
AU3418695A (en) 1996-03-22
ATE302779T1 (de) 2005-09-15
FI113049B (fi) 2004-02-27
CA2198751A1 (en) 1996-03-07
US5795886A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
DE69425162D1 (de) 4,5-diaryloxazol-derivate
MX9800577A (es) Derivados de 4,5-diaril oxazol.
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
WO1998028282A3 (en) OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
ES2149186T3 (es) Derivados de dihidrochalcona hipoglicemicos.
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
WO2001062705A8 (en) Aminoalcohol derivatives
PE46699A1 (es) Compuesto derivado de indol
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
PT1157992E (pt) Derivados de di-hidro-2,3-benzodiazepina
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
DE69914880D1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
EP1213290A4 (en) DIHYDROBENZOFURAN DERIVATIVES, METHOD FOR THEIR PRODUCTION AND MEANS
WO2001064631A3 (fr) Derives de polyfluoroalkylimidazole, leur preparation et leur application en therapeutique
DE60323862D1 (de) 1,2,4-triazolderivat, verfahren zu dessen herstellung, und dieses enthaltende pharmazeutische zusammensetzung
EP1010425A4 (en) THERAPEUTIC AGENTS TO TREAT IRRITABLE COLON
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
WO1996025933A3 (en) Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks